STEVEN ROSINSKI, MD, PHD

New patient office or other outpatient visit, 60-74 minutes

Leuprolide acetate (for depot suspension), 7.5 mg

Biopsy and aspiration of bone marrow sample for diagnosis

Established patient office or other outpatient visit, 40-54 minutes

New patient office or other outpatient visit, 45-59 minutes

Administration of chemotherapy into vein, 1 hour or less

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Established patient office or other outpatient visit, 30-39 minutes

Administration of prolonged chemotherapy into vein

New patient office or other outpatient visit, 30-44 minutes

Drawing of blood for a medical problem

Established patient office or other outpatient visit, 20-29 minutes

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Administration of additional new drug or substance into vein, 1 hour or less

Administration of additional new drug or substance into vein using push technique

Injection, pembrolizumab, 1 mg

Infusion into a vein for hydration, 31-60 minutes

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of chemotherapy into vein, each additional hour

Irrigation of implanted venous access drug delivery device

Injection, denosumab, 1 mg

Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Injection of additional new drug or substance into vein

Injection of drug or substance under skin or into muscle

Infusion into a vein for hydration, each additional hour

Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Injection, zoledronic acid, 1 mg

Injection, leucovorin calcium, per 50 mg

Injection, carboplatin, 50 mg

Infusion, normal saline solution , 1000 cc

Injection, fluorouracil, 500 mg

5% dextrose/water (500 ml = 1 unit)

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Injection, diphenhydramine hcl, up to 50 mg

Infusion, normal saline solution, sterile (500 ml = 1 unit)

Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)

Injection, palonosetron hcl, 25 mcg

Injection, paclitaxel, 1 mg

Injection, granisetron hydrochloride, 100 mcg

Injection, oxaliplatin, 0.5 mg

Injection, dexamethasone sodium phosphate, 1 mg